U.S. pharma large copyright scrapped two experimental weight loss pills final year—a at the time-everyday pill, lotiglipron, because of elevated liver enzymes as well as a two times-day-to-day pill, danuglipron, due to strong Unintended effects—but CEO Albert Bourla has mentioned the company is set to “Engage in and acquire” during the bein